News | News By Subject | News by Disease News By Date | Search News

Emphysema News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News

News from Around the Web
Implantable Air Valves Help Some Emphysema Patients Breathe Easier, University of Groningen Study     12/10/2015
New Research Uncovers Genetic Link Between Emphysema, Lung Cancer, UT Southwestern Medical Center Study     6/9/2011
Protein Could Offer Target to Reduce Lung Damage from Smoking-Caused Emphysema, Indiana University Study     5/17/2011
Protecting the Lungs Against 'Collateral Damage' from the Immune System, University of Alabama at Birmingham Study     9/3/2010
Drug Shields Mice From Chronic Lung Disease, Johns Hopkins University School of Medicine Study     12/23/2008
Life Science Weekly inSite (Sep. 21 - 26)     9/29/2008
Older Emphysema Drug Linked To Heart Deaths, Northwestern University Study     9/17/2008
Acne Drug Doxycycline Prevents Tissue Damage From Emphysema, Leeds University and University of California, San Diego (UCSD) Study     5/16/2008
Combination Therapy Reduces Emphysema Flare-Ups     1/24/2007
FDA Warns Three Pharmacies To Stop Mass-Producing Unapproved Inhalation Drugs     8/11/2006
Wrinkles "Linked To Lung Disease"     6/14/2006
Tomato Juice Keeps Emphysema From Developing In New Model; Lycopene Cited     1/9/2006
Johnny Carson Dies From Common Lung Disease     1/25/2005
Bone Loss Seen With Lung Disease Treatment     1/3/2005
Gene Found To Defend Against Environmental Pollutants And Pulmonary Emphysema     11/11/2004

Press Releases
New Study Demonstrates Benefits Of Pulmonx, Inc. Zephyr Endobronchial Valve In Patients With Homogeneous Emphysema     9/6/2016
Shire (SHPG) And Kamada Ltd. (KMDA) Announce FDA Approval Of Expanded Label For Self-Infusion Of GLASSIA For The Treatment Of Emphysema Due To Severe AAT Deficiency     6/15/2016
Uptake Medical Release: Intervapor Targeted Ablation Therapy Reported As Superior To Standard Medical Management In The Lancet     3/1/2016
Pulmonx, Inc. Completes Enrollment Of Randomized, Prospective, Multi-Center Study In New Patient Population     1/14/2016
The New England Journal of Medicine Publishes Groundbreaking Study Demonstrating Benefits Of Pulmonox Medical’s Medical Device For Emphysema     12/10/2015
Data Confirms Uptake Medical’s InterVapor Significantly Improves Lung Function in Severe Emphysema Patients     10/2/2015
Uptake Medical Receives CE Mark Approval For InterVapor Targeted Ablation Therapy For Severe Emphysema     8/12/2015
Lancet Publication Of Sham-Controlled Clinical Trial Shows Pulmonx, Inc.’s Zephyr Endobronchial Valves Deliver Significant Benefit To Emphysema Patients     7/1/2015
Kamada Ltd. (KMDA.TA) Announces Significantly Improved Infusion Rate For Glassia®     4/24/2014
Kamada Ltd. (KMDA.TA) Announces Completion Of Pivotal Phase 2/3 Clinical Trial In Europe And Canada Of Inhaled AAT To Treat Alpha-1 Antitrypsin Deficiency     12/11/2013
INNOPHARMA Announces FDA Approval of Acetylcysteine Solution, USP, 20% for Inhalation or Oral Administration     9/19/2012
Study Shows Revolutionary New Treatment from Pulmonx, Inc. is Consistently Effective in Treating Emphysema     5/25/2011
Talecris Biotherapeutics (TLCR): Integrated Analysis Demonstrates Alpha(1)-Augmentation Therapy Significantly Reduces Loss of Lung Tissue in Patients with AAT-deficiency-related Emphysema     11/15/2010
BioRx Enters the Alpha-1 Specialty Home Infusion Market     10/13/2010
Pulmonx, Inc. Reports Scientific Publication and Presentations Highlighting Key Advances in Emphysema Treatment     9/28/2010

//-->